2m 2m 2m 2m 2m 2m 2m
Ultragenyx Pharm (RARE)
NASDAQ
$25.98+$0.15 (+0.58%)
Price as of Aug 21, 2026 7:59 PM EDT- $2.5BMarket Cap
- -13.26%1-Year Change
- BiotechnologyIndustry
Ultragenyx Pharm (RARE)
$25.98+$0.15 (+0.58%)
RARE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.83 | ||
Change | +$0.51 (+2.01%) | ||
Open | $25.76 | ||
High | $26.75 | ||
Low | $25.69 | ||
Previous Close | $25.32 | ||
Volume | 2,396,765 | ||
30-Day Average Volume | 2,091,574 | ||
1-Week Change | -2.49% | ||
1-Month Change | -9.75% | ||
1-Year Change | -13.26% | ||
3-Year Change | -30.13% | ||
5-Year Change | -67.78% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $1.3B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.4B | ||
Period: QTR TTM FY | |||
Revenue | $112.0M | ||
Net Income | -$92.0M | ||
Free Cash Flow | -$98.0M | ||
EBIT | -$91.0M | ||
EBITDA | -$83.0M | ||
Net Working Capital | $255.0M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | 22 | ||
P/B | -9 | ||
P/E | -29 | ||
PEG | -1 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue